Template:M gen Equity Derivatives 12.9: Difference between revisions

no edit summary
No edit summary
No edit summary
Line 5: Line 5:
Given that {{eqderivprov|Change in Law}} contains no cure period and {{eqderivprov|Hedging Disruption}} contains a two {{eqderivprov|Scheduled Trading Days}}’ cure period, parties should consider specifying a priority between the two {{eqderivprov|Additional Disruption Events}} in the related {{eqderivprov|Confirmation}}.
Given that {{eqderivprov|Change in Law}} contains no cure period and {{eqderivprov|Hedging Disruption}} contains a two {{eqderivprov|Scheduled Trading Days}}’ cure period, parties should consider specifying a priority between the two {{eqderivprov|Additional Disruption Events}} in the related {{eqderivprov|Confirmation}}.


{{eqderivprov|Failure to Deliver}} applies only to {{eqderivprov|Physically-settled}} {{eqderivprov|Transactions}}. In the synthetic equity world, one doesn’t ride the physically settled bus, so that is one more reason we don’t let it trouble the scorers.
{{eqderivprov|Failure to Deliver}} applies only to {{eqderivprov|Physically-settled}} {{eqderivprov|Transaction}}s. In the synthetic equity world, one doesn’t ride the physically settled bus, so that is one more reason we don’t let it trouble the scorers.